David Thacker
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Cannabis and Cannabinoid Research
- Gastroenterology top 5%
- Gastroesophageal reflux and treatments
Papers in
- Pharmacology 11
- Pharmacogenetics and Drug Metabolism 10
- Inflammatory mediators and NSAID effects 3
- Drug-Induced Hepatotoxicity and Protection 2
- Cannabis and Cannabinoid Research 2
-
- Carbohydrate Chemistry and Synthesis 6
- Co-authors
- David A. Flockhart (7 shared papers)Linda E. Klumpers (1 shared paper)Brian Capon (4 shared papers)Zeruesenay Desta (4 shared papers)Stephen Brimijoin (1 shared paper)Roseann S. Gammal (1 shared paper)Katrin Sangkuhl (1 shared paper)Larisa H. Cavallari (1 shared paper)
- Journals
- Clinical Pharmacology & Therapeutics (4 papers)Pharmacogenomics and Personalized Medicine (1 paper)Journal of Personalized Medicine (1 paper)American Journal of Veterinary Research (1 paper)Pharmaceuticals (1 paper)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
David Thacker
28 papers receiving 685 citations
David Thacker's Hit Papers
Peers
Comparison fields: 5 of 107
- Pharmacology 263
- Gastroenterology 67
- Pharmacology 152
- Toxicology 16
- Pediatrics, Perinatology and Child Health 72
Countries citing papers authored by David Thacker
This map shows the geographic impact of David Thacker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Thacker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Thacker more than expected).
Fields of papers citing papers by David Thacker
This network shows the impact of papers produced by David Thacker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Thacker. The network helps show where David Thacker may publish in the future.
Co-authors
The 25 scholars most cited alongside David Thacker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing Hit paper breakdown → | 2020 | 210 |
| 2 | Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms. | 1997 | 194 |
| 3 | 2018 | 88 | |
| 4 | 1976 | 41 | |
| 5 | 2000 | 40 | |
| 6 | 1998 | 22 | |
| 7 | 2011 | 21 | |
| 8 | 1965 | 20 | |
| 9 | 1997 | 14 | |
| 10 | 1994 | 13 | |
| 11 | 1967 | 10 | |
| 12 | 2012 | 9 | |
| 13 | 1972 | 8 | |
| 14 | 1967 | 8 | |
| 15 | 2021 | 6 | |
| 16 | 1967 | 6 | |
| 17 | 2022 | 4 | |
| 18 | 2021 | 3 | |
| 19 | 1967 | 2 | |
| 20 | 1999 | 2 |
About David Thacker
David Thacker is a scholar working on Pharmacology, Organic Chemistry, Pharmacology, Molecular Biology and Analytical Chemistry, having authored 31 papers that have together received 731 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (10 papers), Carbohydrate Chemistry and Synthesis (6 papers), Analytical Methods in Pharmaceuticals (4 papers), Inflammatory mediators and NSAID effects (3 papers), Enzyme Catalysis and Immobilization (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Pain Management and Opioid Use (2 papers) and Cannabis and Cannabinoid Research (2 papers). The work is most often cited by research in Pharmacology (263 citations), Gastroenterology (67 citations), Pharmacology (152 citations), Toxicology (16 citations) and Pediatrics, Perinatology and Child Health (72 citations). David Thacker has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include David A. Flockhart, Linda E. Klumpers, Brian Capon, Zeruesenay Desta, Stephen Brimijoin, Roseann S. Gammal, Katrin Sangkuhl, Larisa H. Cavallari, Takahisa Furuta and Nihal El Rouby. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Pharmacogenomics and Personalized Medicine, Journal of Personalized Medicine, American Journal of Veterinary Research and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.